ImmunoCellular Therapeutics (IMUC) Trims Number of Shares in Expected Stock Offering
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
ImmunoCellular Therapeutics (NYSE: IMUC) filed Post-Effective Amendment No. 1 to its Registration Statement on Form S-1. In part, the filing said that the company plans to sell 45 million shares of its common stock, down from 51.5 million shares prior.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AK Steel (AKS) Prices 65M Share Common Stock Offering for Proceeds of ~$318.5M
- Theravance Biopharma (TBPH) Announces $100M Shares, $150M Conv. Stock Offerings
- VSE Corp. (VSEC) Reports Q3 EPS of $0.65